trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Adverse reaction rates observed in clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that adverse reaction rates observed in clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug?

Yes. Adverse reaction rates from different clinical trials cannot be directly compared due to inconsistent reporting standards, unstandardized terminology, and differing trial methodologies across studies.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The claim addresses the methodological challenges of cross-study adverse event comparisons. The retrieved papers consistently discuss how unstandardized adverse event definitions, disparate reporting practices between registries and publications, and methodological differences across clinical trials make direct comparisons problematic and uncertain.

Evidence for · 4
Cross-sectional analysis of safety reporting in sleep disorder clinical trials.
2026
Highlights pervasive discrepancies in adverse event definitions, registries, and publications, indicating that unstandardized trial reporting makes cross-study comparisons unreliable.
Get citation
M, L., C, F., K, K., R, H., T, H., D, A., L, C., AI, F., & M, V. (2026). Cross-sectional analysis of safety reporting in sleep disorder clinical trials.. doi.org. https://doi.org/10.1136/bmjopen-2025-112962

See more details
More for · 3
MedDRA adoption and adverse event reporting quality in gastrointestinal and abdominal surgery randomised controlled trials: a cross-sectional analysis.
2026
Shows that unstandardized terminology and variable adverse event reporting quality complicate evidence synthesis across clinical studies.
Get citation
NC, C., K, K., N, C., J, S., R, L., & M, V. (2026). MedDRA adoption and adverse event reporting quality in gastrointestinal and abdominal surgery randomised controlled trials: a cross-sectional analysis.. doi.org. https://doi.org/10.1136/bmjopen-2026-117978

Toward more accurate adverse event attribution in multiple myeloma clinical trials.
2026
Discusses systematic limitations in adverse event attribution, terminology, and grading frameworks that undermine comparisons in clinical trials.
Get citation
M, B. & PM, V. (2026). Toward more accurate adverse event attribution in multiple myeloma clinical trials.. doi.org. https://doi.org/10.1038/s41408-026-01590-z

Tezepelumab (Tezspire): Indication: As an add-on maintenance treatment with intranasal corticosteroids in adult patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) inadequately controlled by systemic corticosteroids and/or surgery: Reimbursement Recommendation
2026
Notes that indirect comparisons between drug trials carry high uncertainty due to methodological limitations and differences between trial designs.
Get citation
Tezepelumab (Tezspire): Indication: As an add-on maintenance treatment with intranasal corticosteroids in adult patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) inadequately controlled by systemic corticosteroids and/or surgery: Reimbursement Recommendation. (2026). europepmc.org. https://europepmc.org/article/MED/42485479

What does the evidence say?

The claim addresses the methodological challenges of cross-study adverse event comparisons. The retrieved papers consistently discuss how unstandardized adverse event definitions, disparate reporting practices between registries and publications, and methodological differences across clinical trials make direct comparisons problematic and uncertain.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work